Résumé :
|
[BDSP. Notice produite par INIST-CNRS JGp1R0xG. Diffusion soumise à autorisation]. Migraine is a common, debilitating and costly disorder. Yet help-seeking for and rates of diagnosis of migraine are low. Drawing on ethnographic observations of pharmaceutical marketing practices at professional headache conferences and a content analysis of migraine advertising, principally in the USA, this paper demonstrates : (1) that the pharmaceutical industry directs its marketing of migraine medication to women ; and (2) as part of this strategy, pharmaceutical advertisements portray women as the prototypical migraine sufferer, through representations that elicit hegemonic femininity. This strategy creates the impression that migraine is a "women's disorder", which, in turn, exacerbates gender bias in help seeking and diagnosis of migraine and reifies presumptions about the epidemiology of the disorder. I conclude that these pharmaceutical marketing practices have a paradoxical effect : even as they educate and raise awareness about migraine, they also create barriers to help seeking and diagnosis.
|